Increased serum asprosin is correlated with diabetic nephropathy
Open Access
- 1 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetology & Metabolic Syndrome
- Vol. 13 (1), 1-6
- https://doi.org/10.1186/s13098-021-00668-x
Abstract
The adipokine asprosin, which was recently discovered, facilitates hepatic glucose production. The aim of this study is to see whether serum asprosin concentrations are linked to diabetic nephropathy (DN). We performed this investigation in a group of 212 type 2 diabetes (T2DM) patients. These patients were classified into three subgroups: DN0 group (normal to mildly increased), DN1 group (moderately increased), and DN2 group (severely increased) on the basis of urine albumin-to-creatinine ratio (ACR). When compared to the controls, T2DM patients had higher serum asprosin levels. The DN2 group had significantly higher serum asprosin than the DN0 and DN1 groups. Furthermore, the DN1 group had higher serum asprosin than the DN0 group. Serum asprosin was linked to a higher risk of T2DM and DN in a logistic regression analysis. Serum asprosin was found to be positively related with disease duration, systolic blood pressure, blood urea nitrogen, creatinine, uric acid, ACR, calcium channel blockers, and angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy, but negatively related with glomerular filtration rate, metformin, and acarbose therapy. Serum asprosin increase with the progression of DN. Serum asprosin is correlated with renal function and ACR.Keywords
Funding Information
- Qingdao Applied Basic Research Program (19-6-2-48-cg)
This publication has 22 references indexed in Scilit:
- 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021Diabetes Care, 2020
- Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney DiseaseInternational Journal of Molecular Sciences, 2019
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscleJournal of Cellular Physiology, 2019
- NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer DevelopmentFrontiers in Immunology, 2018
- A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: AsprosinThe American Journal of Emergency Medicine, 2018
- Clinical usefulness of Glycated Albumin in the diagnosis of diabetes: Results from an Italian studyClinical Biochemistry, 2018
- Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin SecretionMediators of Inflammation, 2018
- Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglycerideClinica Chimica Acta; International Journal of Clinical Chemistry, 2017
- Biomarkers of diabetic nephropathy: A 2017 updateCritical Reviews in Clinical Laboratory Sciences, 2017
- Prevalence and incidence of diabetes mellitus: a nationwide population‐based pharmaco‐epidemiological study in SwedenDiabetic Medicine, 2015